Results: 1-5 |
Results: 5

Authors: Shotland, LI Ondrey, FG Mayo, KA Viner, JL
Citation: Li. Shotland et al., Recommendations for cancer prevention trials using potentially ototoxic test agents, J CL ONCOL, 19(6), 2001, pp. 1658-1663

Authors: Hawk, ET Viner, JL
Citation: Et. Hawk et Jl. Viner, Chemoprevention in ulcerative colitis: Narrowing the gap between clinical practice and research, ANN INT MED, 134(2), 2001, pp. 158-160

Authors: Hassan, R Viner, JL Wang, QC Margulies, I Kreitman, RJ Pastan, I
Citation: R. Hassan et al., Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin,a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma, J IMMUNOTH, 23(4), 2000, pp. 473-479

Authors: Shinohara, H Fan, D Ozawa, S Yano, SJ Van Arsdell, M Viner, JL Beers, R Pastan, I Fidler, IJ
Citation: H. Shinohara et al., Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin, INT J ONCOL, 17(4), 2000, pp. 643-651

Authors: Kelloff, GJ Crowell, JA Steele, VE Lubet, RA Malone, WA Boone, CW Kopelovich, L Hawk, ET Lieberman, R Lawrence, JA Ali, I Viner, JL Sigman, CC
Citation: Gj. Kelloff et al., Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents, J NUTR, 130(2), 2000, pp. 467S-471S
Risultati: 1-5 |